Sale price marks roughly a 47% decline from the biotech firm’s purchase 5 years ago The commercial real estate market in California's biotech corridor is testing investor appetite for vacant buildings, as pharmaceutical giant Amgen Inc. prepares to sell a nearly 100,000-square-foot property in Thousand Oaks at roughly half what it paid six years ago. […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.

Signup for news and special announcements!
You have successfully joined our subscriber list.
Irvine-based Premier Workspaces has committed to more than a decade at Irvine...
ByThe RegistryNovember 10, 2026Santa Ana-based Red Mountain Group has put its fully leased, four-tenant building...
ByThe RegistryNovember 10, 2026Strauss Investments signed an undisclosed tenant in August to 11,423 square feet...
ByThe RegistryNovember 7, 2026The owner of Del Mar Gateway, a fully leased eight-story office building...
ByThe RegistryNovember 5, 2026Error: Contact form not found.